Literature DB >> 9915423

Do we have a prostate specific antigen for bladder cancer?

M S Soloway.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9915423     DOI： 10.1016/s0022-5347(01)61920-7

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  5 in total

1.  Low utility of CYFRA 21-1 serum levels for diagnosis and follow-up in bladder cancer patients.

Authors:  Daniel Fatela-Cantillo; Antonio Fernández-Suárez; Violeta Menéndez; Juan Antonio Galán; Xavier Filella
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

2.  Bladder cancer 2000: molecular markers for the diagnosis of transitional cell carcinoma.

Authors:  D Chao; S J Freedland; A J Pantuck; A Zisman; A S Belldegrun
Journal:  Rev Urol       Date:  2001

Review 3.  Molecular Oncology of Bladder Cancer from Inception to Modern Perspective.

Authors:  Soum D Lokeshwar; Maite Lopez; Semih Sarcan; Karina Aguilar; Daley S Morera; Devin M Shaheen; Bal L Lokeshwar; Vinata B Lokeshwar
Journal:  Cancers (Basel)       Date:  2022-05-24       Impact factor: 6.575

Review 4.  Laparoscopic retroperitoneal lymph node dissection for nonseminomatous testicular carcinoma.

Authors:  Stefan Corvin; Markus Kuczyk; Aristotelis Anastasiadis; Arnulf Stenzl
Journal:  World J Urol       Date:  2004-03-19       Impact factor: 4.226

5.  Rationale for an early detection program for bladder cancer.

Authors:  Makarand V Khochikar
Journal:  Indian J Urol       Date:  2011-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.